Foresite Capital Management III as of Sept. 30, 2021
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 6 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 48.8 | $35M | 2.0M | 18.00 | |
| Acceleron Pharma | 25.9 | $19M | 109k | 172.10 | |
| Verona Pharma Sponsored Ads (VRNA) | 8.4 | $6.1M | 1.1M | 5.48 | |
| Cymabay Therapeutics | 8.3 | $6.0M | 1.6M | 3.65 | |
| Epizyme | 7.1 | $5.1M | 998k | 5.12 | |
| Novavax (NVAX) | 1.4 | $1.0M | 5.0k | 207.40 |
